319 related articles for article (PubMed ID: 28965585)
41. Results of treatment of Wilson's disease--own observations.
Jabłońska-Kaszewska I; Drobińska-Jurowiecka A; Dabrowska E; Trocha H
Med Sci Monit; 2003 Aug; 9 Suppl 3():9-14. PubMed ID: 15156603
[TBL] [Abstract][Full Text] [Related]
42. Wilson's disease: assessment of D-penicillamine treatment.
Van Caillie-Bertrand M; Degenhart HJ; Luijendijk I; Bouquet J; Sinaasappel M
Arch Dis Child; 1985 Jul; 60(7):652-5. PubMed ID: 4026361
[TBL] [Abstract][Full Text] [Related]
43. Management Perspective of Wilson's Disease: Early Diagnosis and Individualized Therapy.
Yuan XZ; Yang RM; Wang XP
Curr Neuropharmacol; 2021; 19(4):465-485. PubMed ID: 32351182
[TBL] [Abstract][Full Text] [Related]
44. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine].
D'Addabbo A; Damato VD; Germinario L; Campanella G; Boccuni N
Acta Neurol (Napoli); 1971; 26(4):436-48. PubMed ID: 5132825
[No Abstract] [Full Text] [Related]
45. Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice.
Hoogenraad TU
Brain Dev; 2006 Apr; 28(3):141-6. PubMed ID: 16466879
[TBL] [Abstract][Full Text] [Related]
46. Tracing copper-thiomolybdate complexes in a prospective treatment for Wilson's disease.
Zhang L; Lichtmannegger J; Summer KH; Webb S; Pickering IJ; George GN
Biochemistry; 2009 Feb; 48(5):891-7. PubMed ID: 19146437
[TBL] [Abstract][Full Text] [Related]
47. Observation on the changes of clinical symptoms, blood and brain copper deposition in Wilson disease patients treated with dimercaptosuccinic acid for 2 years.
Zhou XX; Pu XY; Xiao X; Chen DB; Wu C; Li XH; Liang XL
J Clin Neurosci; 2020 Nov; 81():448-454. PubMed ID: 33222961
[TBL] [Abstract][Full Text] [Related]
48. Treatment of Wilson's disease with zinc: III. Prevention of reaccumulation of hepatic copper.
Brewer GJ; Hill GM; Dick RD; Nostrant TT; Sams JS; Wells JJ; Prasad AS
J Lab Clin Med; 1987 May; 109(5):526-31. PubMed ID: 3572199
[TBL] [Abstract][Full Text] [Related]
49. Biomedical copper speciation in relation to Wilson's disease using strong anion exchange chromatography coupled to triple quadrupole inductively coupled plasma mass spectrometry.
Solovyev N; Ala A; Schilsky M; Mills C; Willis K; Harrington CF
Anal Chim Acta; 2020 Feb; 1098():27-36. PubMed ID: 31948584
[TBL] [Abstract][Full Text] [Related]
50. Resolution of Wing-Beating Tremor and Magnetic Resonance Imaging Lesions in Wilson's Disease Following Penicillamine.
Brum IV; Parmera JB; Otani RTV; Prates IR; Lucato LT; Cury RG; Barbosa ER
Tremor Other Hyperkinet Mov (N Y); 2024; 14():9. PubMed ID: 38464913
[TBL] [Abstract][Full Text] [Related]
51. Two-dimensional mapping of copper and zinc in liver sections by laser ablation-inductively coupled plasma mass spectrometry.
Kindness A; Sekaran CN; Feldmann J
Clin Chem; 2003 Nov; 49(11):1916-23. PubMed ID: 14578324
[TBL] [Abstract][Full Text] [Related]
52. D-Penicillamine improved laparoscopic and histological findings of the liver in a patient with Wilson's disease: 3-year follow-up after diagnosis of Coombs-negative hemolytic anemia of Wilson's disease.
Sakaida I; Kawaguchi K; Kimura T; Tamura F; Okita K
J Gastroenterol; 2005 Jun; 40(6):646-51. PubMed ID: 16007400
[TBL] [Abstract][Full Text] [Related]
53. [Hereditary Liver Diseases: Wilson's Disease and Hemochromatosis].
Merle U; Mohr I
Dtsch Med Wochenschr; 2023 Jul; 148(13):836-843. PubMed ID: 37364578
[TBL] [Abstract][Full Text] [Related]
54. Copper and zinc concentrations in the breast milk of mothers undergoing treatment for Wilson's disease: a prospective study.
Kodama H; Anan Y; Izumi Y; Sato Y; Ogra Y
BMJ Paediatr Open; 2021; 5(1):e000948. PubMed ID: 34222678
[TBL] [Abstract][Full Text] [Related]
55. Quantitative bioimaging of copper in frozen liver specimens from cats using laser ablation-inductively coupled plasma-mass spectrometry.
Yamkate P; Funke S; Steiger K; Gold RM; Lidbury JA; Karst U; Steiner JM
J Feline Med Surg; 2023 Jul; 25(7):1098612X231186919. PubMed ID: 37522313
[TBL] [Abstract][Full Text] [Related]
56. Psychosis in an adolescent patient with Wilson's disease: effects of chelation therapy.
McDonald LV; Lake CR
Psychosom Med; 1995; 57(2):202-4. PubMed ID: 7792379
[TBL] [Abstract][Full Text] [Related]
57. [Checking of urinary copper in patients with Wilson's disease during treatment with D-penicillamine].
Indaco A; Pellegrino L; Campanella G
Acta Neurol Quad (Napoli); 1979; 39():160-4. PubMed ID: 555232
[No Abstract] [Full Text] [Related]
58. A comparison of the effects of penicillamine, trientine, and trithiomolybdate on [35S]-labeled metallothionein in vitro; implications for Wilson's disease therapy.
McQuaid A; Mason J
J Inorg Biochem; 1991 Feb; 41(2):87-92. PubMed ID: 2033396
[TBL] [Abstract][Full Text] [Related]
59. Hypersomnia in Wilson's disease: an unusual symptom in an unusual case.
Firneisz G; Szalay F; Halasz P; Komoly S
Acta Neurol Scand; 2000 Apr; 101(4):286-8. PubMed ID: 10770529
[TBL] [Abstract][Full Text] [Related]
60.
Pu Y; Zhang J; Peng N; Li R; Xie DJ; Zhang RX; Sun LT; Wang JL; Ye H
J Pharm Biomed Anal; 2023 May; 229():115355. PubMed ID: 37018958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
